ライフサイエンスコーパス: type II

1 cones either not tilted (type I) or tilted (type II).

2 ter genomes suggests a close relationship to Type II.

3 trated that RCCR activity of olive fruits is type II.

4 e was type I (50.3%), with type III (29.6%), type II (14.5%) and type IV (5.7%).

5 s from high-energy to low-energy states in a type-II 2D InSe/GaAs heterostructure.

6 In type II-A CRISPR, however, Cas1-Cas2 alone integrates sp

7 analysis led to the discovery of four unique type II-A CRISPR-Cas9 inhibitor proteins encoded by List

8 shown to block the endonuclease activity of type II-A Streptococcus pyogene Cas9 (SpyCas9).

9 e present four structural snapshots from the type II-A system of Enterococcus faecalis Cas1 and Cas2

10 In Type II ABC transporters (importers of trace elements, e

11 We propose that other Type II ABC transporters likely share the fundamentals o

12 ally uses two type I (ALK2 and ALK3) and two type II (ActRIIA and BMPR2) BMP receptors.

13 of proliferating and IAV-infected, alveolar type II (AECII) cells in dispersed lung cell populations

14 y expressed in apical and Cgrpalpha in basal type II afferent neurons, indicating heterogeneity among

15 rent neurons, indicating heterogeneity among type II afferent neurons.

16 Despite these many contacts, type II afferents are insensitive to sound and only weak

17 Recent studies suggest that type II afferents may be cochlear nociceptors, and can b

18 pares the expression patterns among cochlear type II afferents of two genes found in C-fibers: calcit

19 e presence and the branch of arabinogalactan type II (AGII) structure.

20 We further demonstrate that type I and type II agonists have a distinct impact on TRPM8 current

21 ted by break-induced replication, similar to type II ALT survivors in Saccharomyces cerevisiae Replic

22 acrine communication between macrophages and type II alveolar epithelial cells during influenza infec

23 icant positive correlation between CDC42 and type II alveolar epithelial cells marker SP-A, indicatin

24 RhoA was localised in actin nodules with PKA type II and a number of other phosphorylated PKA substra

25 he induction of type I IFN or the effects of type II and III IFNs but were associated with altered lo

26 matrix, and laminin-alpha1 enhanced collagen type II and reduced collagen type I expression by cultur

27 A/1 mice were immunised with bovine collagen type II and treated orally with specific CDK9 inhibitors

28 ciliated cells in the conducting airways and type II and type I cells lining the alveoli.

29 -helices typically consisting of mixtures of type II and type IV beta-turns.

30 We conclude that collagen type-II and CS can be used to promote a more chondrogeni

31 e distinct types of ependymal cilia, type-I, type-II and type-III classified based upon their beating

32 Root apices narrowed significantly in types II and III, but not in type I patients.

33 apical calcification bridge formed in 47.2% (type II) and apical closure (type III) in 38.9% cases.

34 d Ca(2+)/calmodulin-dependent protein kinase type II) and development of caveolin-mediated signaling

35 k nodes (type I), (ii) metal node extension (type II), and (iii) metal coordination to the organic li

36 rferon (IFN-alpha/beta) (type I), IFN-gamma (type II), and IFN-lambda (type III).

37 5%) were classified as type I, 17 (26.2%) as type II, and 21 (32.4%) as type III.

38 Here, we reveal that, in contrast to Type I, Type II animal cryptochromes lack the structural feature

39 highly effective bifunctional linchpins for type II anion relay chemistry (ARC) has been achieved.

40 Key synthetic transformations include Type II Anion Relay Chemistry (ARC) to construct the pol

41 Obinutuzumab (OBZ) is a recombinant type II anti-CD20 and immunoglobulin G1 Fc-optimized mon

42 S365L and I207T, present in individuals with type II antithrombin deficiency and identified a new ant

43 icantly increased metacognitive performance (type-II area under the curve, AUROC2), but had no impact

44 The type II arginine methyltransferase PRMT5 is responsible

45 oli (EcAII) and Erwinia chrysanthemi (ErAII) type II ASNases currently used in the clinics are charac

46 Alveolar type II (AT2) cell dysfunction contributes to a number o

47 soform deletion specifically in the alveolar type II (ATII) cells of adult mice.

48 in lung homogenates and alveolar epithelial type II (ATII) cells of never-smokers, smokers, patients

49 usality (causal relationship suggested), and type II autoimmunity has level 2 causality (causal relat

50 are at least 2 distinct pathways, type I and type II autoimmunity, that contribute to the pathogenesi

51 Here we show that the type II-B FnCas9 from Francisella novicida possesses nov

52 odetectors can be achieved by exploiting the type-II band alignment of vertically stacked WS2 /MoS2 s

53 Type II Bartter syndrome is caused by mutations in the r

54 ology for at least a subset of patients with type II Bartter syndrome is linked to the ERAD pathway a

55 ich the cup comprises the CTD and an ensuing type II beta-turn, and the stem comprises a 6-helix bund

56 ther PRPs, At2g44920 consists exclusively of type II beta-turns.

57 milarly, conditional genetic deletion of the type II BMP receptor in Ascl1-expressing cells promoted

58 ptor-positive, expressing carbonic anhydrase type II, but relatively low levels of cathepsin K.

59 ble to diverse CRISPR-Cas systems, including type II-C Cas9 and type V Cpf1 systems, and can facilita

60 Thus, Type II cadherins may uniquely contribute to the specifi

61 ological tools beyond the well-characterized Type II Cas9 systems.

62 Exposure of the human-type II cell alveolar epithelial cells (A549) to DPM der

63 TF-1-driven mediators of SP-A expression and type II cell differentiation through repression of TGF-b

64 ions of mouse taste cells: Tas1r3-expressing type II cells and physiologically identified type III ce

65 Basal, secretory and type II cells can be grown in three-dimensional culture,

66 Idiopathic pulmonary fibrosis lung alveolar type II cells have increased MnSOD(K68) acetylation comp

67 ela1 was expressed predominantly in alveolar type II cells in the embryonic lung and predominantly in

68 ng responses to stimuli were up-regulated in type II cells, while pathways related to neuronal functi

69 nd 5-deoxyflavanones, resembling the typical type II CHIs currently known to be 'specific' for legume

70 HIs, suggest that emergence of the bona fide type II CHIs is an ancient evolution event that occurred

71 iscovered that these differences require the Type II classic cadherins, cadherins-6, -9, and -10.

72 plicity of site-specific genome targeting by type II clustered, regularly interspaced, short palindro

73 yseal dysplasias, are linked to mutations in type II collagen (COL2A1), but the causative gene in SEM

74 B6.DR1/LAIR-1(-/-) mice were immunized with type II collagen they developed more severe arthritis an

75 Significantly higher levels of type II collagen were noted when pericytes undergo chond

76 ly - significantly upregulated expression of type II collagen, compared to type-I and pure type-II sc

77 ent protease responsible for the cleavage of type II collagen, the major structural protein of articu

78 esis of secretome components, resulting in a type II collagen-rich matrix that promotes tumour progre

79 enerate cartilage-like structures containing type II collagen.

80 B6.DR1 mice were immunized with type II collagen/CFA to induce arthritis and were treate

81 Monomeric type-I and type-II collagen scaffolds, which avoid potential immuno

82 Type II cracks were predominant on noncontacting surface

83 structural comparison of AsCpf1 with Cas9, a type II CRISPR-Cas nuclease, reveals both striking simil

84 Notably, we identified the first type II CRISPR-Cas systems encoded by members of the Can

85 in Staphylococcus aureus cells harbouring a type II CRISPR-Cas9 system after infection with the stap

86 ficant implications for the putative role of Type II cryptochromes in animal photomagnetoreception.

87 The crystals grew with a type II crystal lattice in contrast to the typical type

88 ing alters both the number of ILC2 and their type II cytokine production.

89 phoid cells (ILC2) are a prominent source of type II cytokines and are found constitutively at mucosa

90 White women with type II diabetes (T2D) have an estimated 20% increased r

91 associated with Alzheimer's disease (AD) and type II diabetes (T2D), respectively.

92 esity poses a significant risk of developing type II diabetes and other diseases.

93 Conditions such as type II diabetes are linked with elevated lipid levels i

94 rlying the development of cardiac disease in type II diabetes are not fully understood.

95 ence suggests that mitoNEET, a target of the type II diabetes drug pioglitazone, is a key regulator o

96 Type II diabetes mellitus was associated with higher ris

97 key therapeutic target in the management of type II diabetes mellitus, with actions including regula

98 ed and small unmyelinated axons in the db/db type II diabetes mouse model.

99 s have reported mitochondrial dysfunction in type II diabetes patients.

100 inhibits the positive effect of exercise on type II diabetes risk under a HF diet-induced obesity en

101 including Alzheimer and Parkinson diseases, type II diabetes, and a number of systemic amyloidoses.

102 teoporosis, hypercalcaemia, Paget's disease, type II diabetes, and obesity and are being actively pur

103 by stage 4 renal failure from long-standing type II diabetes, hypertension, iron deficiency anemia,

104 ovel therapeutic target for the treatment of type II diabetes, the broad distribution pattern of this

105 with metabolic diseases such as obesity and type II diabetes, the role of specific ACSL isoforms in

106 lso includes two mitochondrial proteins: the type II diabetes-related mitoNEET and the Wolfram syndro

107 IAPP or amylin), the protein associated with type II diabetes.

108 ligomers are one of the cytotoxic species in type II diabetes.

109 cretion, a process impaired in patients with type II diabetes.

110 nzyme for gluconeogenesis and is linked with type II diabetes.

111 d it has become an attractive drug target in type II diabetes.

112 may represent a novel therapeutic target in type II diabetes.

113 ates obesity-mediated insulin resistance and type II diabetes.

114 as Alzheimer's disease, prion diseases, and type II diabetes.

115 hIAPP fibrils are associated with Type-II Diabetes, but the link of hIAPP structure to isl

116 glomeruli that were purified from type I and type II diabetic mice.

117 autonomic neuropathy affects the majority of type II diabetic patients.

118 carboxylase, and three out of five putative type II diglyceride acyltransferases (DGATs), the enzyme

119 ne to N-Boc protected aldimines Type I E and Type II E are active.

120 our pathways (Type I Z, Type I E, Type II Z, Type II E) are possible, leading to different enantiomer

121 differential expression of marker genes for type II (e.g. the Tas1r genes, Plcb2, Trpm5) and type II

122 nificantly associated with (i) primary tumor type; (ii) entropy in SM#2 (same malignant process); (ii

123 C' 3a (C3a) in normal primary human alveolar type II epithelial cells (AECs).

124 Alveolar type II epithelial cells (ATII) are instrumental in earl

125 he lung, LAL is highly expressed in alveolar type II epithelial cells.

126 ting statistical thresholds led to very high Type II error rates.

127 nOCC performs well as measured by type I and type II error rates.

128 or no concern about concomitant increases in Type II errors.

129 frequency drop to zero, which is typical for type II excitability.

130 ow can neural tissue exhibit both type I and type II excitability?

131 quency and small amplitude-the hallmark of a type II excitable medium-yet they also propagate far bey

132 ibitory neurons transformed the model into a type II excitable medium.

133 d, balanced IgG signaling through type I and type II Fc receptors is required for the control of proi

134 uated by immunohistochemistry in the core of type II focal cortical dysplasias (FCD-II), at the FCD b

135 ollination to individual plants best match a Type II functional-response curve.

136 KEY POINTS: Vestibular type I and type II hair cells and their afferent fibres send inform

137 ABSTRACT: Type I and type II hair cells are the sensory receptors of the mamm

138 supporting cells to generate 6 times as many type II hair cells compared to normal conditions.

139 reER(T2)-expressing supporting cells replace type II hair cells.

140 rting cells or by Atoh1-CreER(TM)-expressing type II hair cells.

141 ner core without disturbing the poly-proline type II helical conformation of each chain.

142 polypeptide with unusually high polyproline type II helix propensity.

143 bcutaneous CSL830 in patients with type I or type II hereditary angioedema who had had four or more a

144 talytic site was key to the emergence of the type II HEs.

145 across the heterojunction interface yields a type II heterojunction, in agreement with first-principl

146 of semiconductor nanostructures to create a type-II heterojunction at the semiconductor-water interf

147 lectron-transfer process in the photoexcited type-II heterostructure-a fundamental phenomenon in semi

148 Type II IFN (IFN-gamma) also induces an antiviral state

149 expression potentiated antiviral effects of type II IFN to restrict gammaherpesvirus replication in

150 s can resist a late block that is induced by type II IFN, and the use of chimeric IFN-gamma-sensitive

151 at Rictor is essential for the generation of type II IFN-dependent antiviral and antiproliferative re

152 onses and that it controls the generation of type II IFN-suppressive effects on normal and malignant

153 la virus activity was overlooked, type I and type II IFNs (alpha-2a, alpha-2b, -beta, -gamma, and -un

154 enic immunodeficiency specific to type I and type II IFNs.

155 lusively in clonal hematologic diseases, and type II/III, which is called mixed cryoglobulinemia and

156 complications after Boston keratoprosthesis type II implantation in the largest single-center case s

157 48 eyes of 44 patients had keratoprosthesis type II implanted by 2 surgeons (C.H.D. and J.C.).

158 ort an atypical imaging presentation of CPAM type II in the second trimester, extensively involving a

159 organism's clock to its environment, whereas Type II (including mammals) regulate circadian timing in

160 g studies of the CYP121A1 inhibitors suggest type II indirect binding through interstitial water mole

161 nd type I kinase inhibitor Dasatinib and the type II inhibitor RL45, respectively fail and succeed in

162 gulated expression of IL-33, a stimulator of type II innate lymphoid cells, in lung epithelial cells

163 ed the effects of NAFLD on expression of the type II inositol 1,4,5-trisphosphate receptor (ITPR2), t

164 Inositol polyphosphate 4-phosphatase type II (INPP4B) negatively regulates phosphatidylinosit

165 as well as the production of TLR8-dependent type II interferon (IFN-gamma), TNF-alpha, and IL-12 in

166 eIF4F) and initiation of mRNA translation of type II interferon-stimulated genes.

167 whereas they both produced and responded to Type II interferon.

168 These results demonstrate that type I and type II interferons, together with IL-27, regulate ILC2

169 r determinants governing the assembly of the type II interleukin-4 receptor, taking advantage of vari

170 The Boston keratoprosthesis type II is a viable option to salvage vision in patients

171 gulate K16 with robust downregulation of its type II keratin binding partner, K6.

172 ns revealed the variation in the swelling of type II kerogen in the presence of same amount of differ

173 tructure-based design and synthesis of novel type II kinase inhibitors to overcome these mutations in

174 y aggregation of the basal epidermal keratin type II (KtyII) K5 and its type I partner keratin 14 (K1

175 Arginase-II (Arg-II), the type-II L-arginine-ureahydrolase, is highly expressed in

176 iquid culturing, and these survivors exhibit type II-like as well as ALT-like telomere features.

177 ession of Cgrpalpha in a subset of SGNs with type II-like peripheral dendrites extending beneath OHCs

178 vealing the stabilization of a weak-coupling type-II-like superconductor ([Formula: see text] [Formul

179 that each produce 4-6 GMCs and 8-12 neurons (type II lineage).

180 Thus, type II lineages are similar to primate cortical lineage

181 ons of the central complex, generated by the type II lineages DM1-4, form the posterior EB primordium

182 In in the context of the eight central brain type II lineages, which produce highly diverse progeny t

183 ain development and is associated with human type II lissencephaly.

184 ecting neuron, lobula plate/lobula columnar, type II (LPLC2) in Drosophila, and show how its selectiv

185 tly encompass many key phenotypic regulatory Type II MADS-box gene clades (SEP1, SQUA, TM8, SEP3, FLC

186 1) and sh (AVROS) (M2) in the SHELL gene - a type II MADS-box transcription factor mainly present in

187 ffort of improving the kinase selectivity of type II maternal embryonic leucine zipper kinase inhibit

188 medium but it is locally transformed into a type II medium by optogenetic stimulation which predomin

189 Neprilysins are Type II metalloproteinases known to degrade and inactiva

190 licited by expression of the foreign M.HhaII Type II methytransferase (MTase), as well.

191 cells and induction of antiinflammatory M2 (type II) monocytes.

192 On further cooling to 48 K, a type-II multiferroic phase induced by the special spin s

193 e hypothesis that muscles rich in type I vs. type II muscle fibers would exhibit similar changes in i

194 2 was predominantly contained in fast twitch/type II myofibers.

195 ursor nodes that include the molecular motor type-II myosin Myo2 and the actin assembly factor formin

196 In fission yeast, cytokinesis involves the type II myosins Myo2p and Myp2p and the type V myosin My

197 Type II NADH:quinone oxidoreductase (NDH-2) is central t

198 y mechanism of Notch-mediated maintenance of type II NB self-renewal and identity, but also reveals a

199 expressed Erm promotes the transformation of type II NBs into type I NBs by inhibiting PntP1 function

200 inhibiting PntP1 function and expression in type II NBs.

201 With Acute Heparin-induced Thrombocytopenia Type II; NCT01304238).

202 the adult central complex, as do the larval type II neuroblast progeny?

203 Embryonic type II neuroblasts and INPs undergo quiescence, and pro

204 t molecular and clonal data showing that all type II neuroblasts form in the embryo, produce INPs and

205 Yet the origin of type II neuroblasts remains mysterious: do they form in

206 dients create coarse temporal windows within type II neuroblasts to pattern INPs, which subsequently

207 Like mammalian neural stem cells, Drosophila type II neuroblasts utilize INPs to produce neurons and

208 ying temporal fating mechanisms, we profiled type II neuroblasts' transcriptome across time.

209 T cells express diverse TCRs and are termed type II NKT cells.

210 the effect of fluoxetine on proliferation of type II NSCs and neuroblast populations in the ventral h

211 aused by deficiency (type I) or dysfunction (type II) of the C1 inhibitor protein.

212 showed that cells produced abundant collagen type-II on type-II scaffolds and collagen type-I on type

213 sitization and, consequently, are classed as type II PAMs.

214 f action compare with other alpha7-selective type II PAMs.

215 finding also translates to large networks of type-II phase oscillators and, hence, crucially impacts

216 tRNA could be expressed from RNA polymerase type II (pol II) promoters such as generic CMV and muscl

217 processes enable convergent construction of type II polyketide substructures.

218 (miRNA) gene architecture that uses RNAP III type II promoters.

219 ype IV pilus assembly is homologous with the type II protein secretion complex.

220 Here we demonstrate that Prx type II (PrxII) plays a tumor-promoting role in colorect

221 In both laminar zones, Type II PV-IR synapses from interneurons comprised appro

222 dendritic shafts of PV-IR interneurons, (3) Type II PV-IR synapses from PV interneurons, and (4) Typ

223 0,000 fold) of resistance to both type I and type II pyrethroids.

224 ressed in Xenopus oocytes to both type I and type II pyrethroids.

225 Many type II R-M systems are plasmid-based and thus capable o

226 Refractory celiac disease type II (RCDII) is a severe complication of celiac disea

227 acids under study here can undergo a Norrish Type II reaction to generate pyruvic acid, increasing th

228 quinone or as a hydrogen abstraction-Norrish Type II-reaction.

229 human BCa bone metastatic tissues, TGF-beta type II receptor (TbetaRII) and p-Smad2 were expressed i

230 equired for TGF-beta signaling, the TGF-beta type II receptor (TbetaRII), as an alternative therapeut

231 of miR302 effected silencing of the TGFbeta type II receptor and facilitated plasticity in a manner

232 TGFbeta signaling cooperatively with TGFbeta type II receptor in colon cancer cells, enhancing TGFbet

233 exhibits a preference for Wit over the other type II receptor Punt.

234 recent progress, the regulation of TGF-beta type II receptor remains uncertain.

235 oma expression, which stabilized the TGFbeta Type II receptor sensitizing PDAC cells to TGFbeta-media

236 through its regulation of pupal ecdysis in a type II receptor Wishful thinking (Wit)-dependent manner

237 mutations in the bone morphogenetic protein type-II receptor (BMPR-II) gene underlie heritable pulmo

238 a the ALK2 type I receptor, BMPR-II/ACTR-IIA type II receptors, and downstream Smad1/5 signaling.

239 The type II receptors, BMPR-II and ACTR-IIA were both requir

240 eptor activin receptor-like kinase 1 (ALK1), type II receptors, co-receptor endoglin, or to mature BM

241 or that blocks the ligand binding epitope on type II receptors.

242 In the majority of organs tested, type II regulatory (RII) subunits were found to be the p

243 Pneumocystis infection generates a strong type II response in the lung that requires CD4(+) T cell

244 Type II responses yield stable persistence in a U-shaped

245 we report phage 9 g DNA sensitivity to >200 Type II restriction endonucleases (REases).

246 Although all Type II restriction endonucleases catalyze phosphodieste

247 changes in myolipid metabolism in type I vs. type II rich muscle regions in obesity, perhaps related

248 Association of PKA regulatory type II (RII) subunits with A-kinase-anchoring proteins

249 ates from mitochondrial fatty-acid synthesis type II, S-adenosylmethionine and iron-sulfur clusters.

250 cells produced abundant collagen type-II on type-II scaffolds and collagen type-I on type-I scaffold

251 ype II collagen, compared to type-I and pure type-II scaffolds.

252 late blood coagulation, as the most abundant type II secreted effector protein.

253 Type II secretion (T2S) is one means by which Gram-negat

254 mutants of Legionella pneumophila lacking a type II secretion (T2S) system elicit higher levels of c

255 at A. nosocomialis M2 possesses a functional type II secretion system (T2SS) that is required for ful

256 ogenic species of Acinetobacter, including a type II secretion system (T2SS), a type VI secretion sys

257 ne proteases to be the substrates of the Xps type II secretion system in S. maltophilia strain K279a.

258 ched protein families putatively secreted by type II secretory system: PheA (CM-sec), LipA/LesA, VirK

259 Cgrpalpha starts to express in type II SGNs before hearing onset, but the expression le

260 Type II spiral ganglion neurons (SGNs) are small caliber

261 ype I), Acinetobacter and Moraxella species (type II), Staphylococcus epidermidis (type III), Porphyr

262 tors based on new InAs/InAs1-xSbx/AlAs1-xSbx type-II superlattice design.

263 Microjunction InAs/InAs1-xSbx type-II superlattice-based long-wavelength infrared phot

264 InAs/(InAs,Ga)Sb type II superlattices (T2SLs) with different in-plane ge

265 Type-II superlattices (T2SLs) are a class of artificial

266 Within type-II superlattices, InAs/InAs1-xSbx T2SLs have been s

267 PV): local inhibitory interneurons that form Type II synapses, and long-range glutamatergic inputs fr

268 Ca(2+)-activated cation channel expressed in type II taste receptor cells and pancreatic beta-cells.

269 ctions between the cytoplasmic domain of the type II TGF-beta receptor (TbetaRII) and the FN receptor

270 coexpression of apically targeted type I and type II TGF-beta receptors mediated Smad3 signaling from

271 nding of their cognate ligands to type I and type II TGF-beta receptors, indicating that Cripto-1 and

272 nto type-I that respect Lorentz symmetry and type-II that do not.

273 enerically host a co-existence of type-I and type-II three-dimensional bulk Dirac fermions as well as

274 of merbarone and etoposide and generated new type II topoisomerase (topoII) poisons.

275 ng in Cell, Canela et al. (2017) reveal that type II topoisomerase-mediated release of torsional stra

276 etrahydropyran-based inhibitors of bacterial type II topoisomerases (DNA gyrase and topoisomerase IV)

277 Type II topoisomerases orchestrate proper DNA topology,

278 e resolved through transient DNA fracture by type II topoisomerases to permit chromosome segregation

279 quinolone interactions with other bacterial type II topoisomerases.

280 Cluster of differentiation 38 (CD38) is a type II transmembrane glycoprotein overexpressed in myel

281 describe that ODZ1 (also known as TENM1), a type II transmembrane protein involved in fetal brain de

282 TMPRSS13 is a member of the type II transmembrane serine protease (TTSP) family.

283 gate the role of matriptase, a member of the type II transmembrane serine protease family, in APP pro

284 airway trypsin-like protease 4 (HAT-L4) is a type II transmembrane serine protease.

285 We have previously demonstrated that the type II transmembrane serine proteinase (TTSP) matriptas

286 onic structure of MoTe2, a recently proposed type-II TWS.

287 tic properties and practical applications of type-II TWSs, as well as the interplay between supercond

288 npcc7942_2071 encodes an ATPase homologue of type II/type IV systems.

289 wn previously to be a selective biomarker of type II versus type I cochlear afferents (Vyas et al., )

290 ied: Type I - superficial horizontal cracks; Type II - vertically (occluso-gingival) oriented cracks;

291 other methods to demonstrate that utricular type II vestibular hair cells undergo turnover in adult

292 s of TBPH caused a reduction in cacophony, a Type II voltage-gated calcium channel, expression and th

293 of congenital pulmonary airway malformation type II was made.

294 st Landau level under high magnetic field in type II Weyl semimetal YbMnBi2.

295 erved in the time reversal symmetry breaking type II Weyl semimetal YbMnBi2.

296 es' that form closed loops and are unique to type II Weyl semimetals.

297 n its orthorhombic T d polymorph, MoTe2 is a type-II Weyl semimetal, where the Weyl fermions emerge a

298 ted cartilage, with chondromodulin, collagen types II/X downregulated, deiodinase II and netrin-1 upr

299 Type I Z and Type II Z are demonstrated to be the competing pathways

300 reactions four pathways (Type I Z, Type I E, Type II Z, Type II E) are possible, leading to different